
Daratumumab in multiple myeloma: Reassessment shows hint of considerable added benefit
An early benefit assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in 2020 already addressed the question of whether daratumumab in combination with lenalidomide and dexamethasone ...
Jan 4, 2022
0
14